Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers

Farese, Stefan; Stauffer, Emilie; Kalicki, Robert; Hildebrandt, Tatjana; Frey, Brigitte M; Frey, Felix J; Uehlinger, Dominik E; Pasch, Andreas (2011). Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clinical journal of the American Society of Nephrology, 6(6), pp. 1447-55. Washington, D.C.: American Society of Nephrology 10.2215/CJN.10241110

Full text not available from this repository. (Request a copy)

Vascular calcification is a major cause of morbidity and mortality in dialysis patients. Human and animal studies indicate that sodium thiosulfate (STS) may prevent the progression of vascular calcifications. The pharmacokinetics of STS in hemodialysis patients has not been investigated yet.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension

UniBE Contributor:

Farese, Stefan, Kalicki, Robert, Frey, Brigitte, Frey, Felix (B), Uehlinger, Dominik

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1555-9041

Publisher:

American Society of Nephrology

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:17

Last Modified:

29 Mar 2023 23:32

Publisher DOI:

10.2215/CJN.10241110

PubMed ID:

21566113

Web of Science ID:

000291500900030

URI:

https://boris.unibe.ch/id/eprint/5341 (FactScience: 210081)

Actions (login required)

Edit item Edit item
Provide Feedback